Substrate characterization and outcomes of ventricular tachycardia ablation in amyloid cardiomyopathy: a worldwide study

7 April 2024 (08:30 - 15:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Paolo Compagnucci

University Hospital Riuniti of Ancona, Ancona (Italy)

6 More presentations in this session

Presentation thumbnail

Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach

Doctor S. Vazquez-Calvo (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Impact of functional gene groups on outcomes after ablation of ventricular tachycardia in patients with inherited left ventricular cardiomyopathy: an international multicentre study

Doctor Y. Kimura (Leiden, NL)

Abstract Slides Video

Presentation thumbnail

First experience of focal pulsed field ablation for premature ventricular contractions

Doctor M. Cespon Fernandez (Vigo, ES)

Abstract Slides Video

Presentation thumbnail

Identification of reentry vulnerable targets during substrate mapping for ablation in scar related VT: the "visual" reentry vulnerability index

Doctor J. Tonko (London, GB)

Abstract Slides Video

Presentation thumbnail

Neural network for automatic ICD-EGMs matching in pace-mapping and ablation of ventricular arrhythmias.

Doctor E. Lian (Kiel, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Ventricular tachycardia: ablation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024

You may be interested in

Congress Presentation

Reduced heart failure hospitalizations and improved quality of life in cardiac amyloidosis patients undergoing atrial fibrillation ablation

Congress Presentation

Management of arrhythmias in cardiac amyloidosis

Congress Session

Therapeutic advances in amyloid cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources